ArticleBlood cancer journal2011

Pacritinib (SB1518), a JAK2/FLT3 inhibitor for the treatment of acute myeloid leukemia.

S Hart et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.